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Background: The pathophysiology of functional abdominal pain (FAP) is unknown. The upright portion of a tilt table test triggers
typical symptoms in certain children. Aim: To compare the pathophysiology and treatment response of children with FAP whose
gastrointestinal symptoms (GI) were replicated (RGI) by tilt table testing (TTT) to those in whom TTT did not have this eﬀect
(NRGI). Methods: An IRB-approved retrospective review of the autonomic laboratory database identiﬁed all children tested for
GI complaints. We compared results of TTT, Valsalva maneuver, deep breathing and the axon reﬂex sweat test. Overall treatment
response and that speciﬁc to ﬂudrocortisone was ranked from 1 to 5, with 1 “much worse,” 3 “neutral,” and 5 “much better.”
Results: 32/76 identiﬁed children had reproducible symptoms on TTT (RGI) and 44 did not (NRGI). The RGI group was younger,
had a shorter duration of symptoms, more postural tachycardia syndrome (POTS) and beneﬁted more from ﬂudrocortisone (73%
in RGI vs. 25% in NRGI). Conclusion: Dividing patients with FAP according to the eﬀe c to fT T To nt h e i rs y m p t o m sa p p e a r st o
delineate 2 fundamentally diﬀerent groups, with potentially diﬀerent pathophysiologies and treatment responses. A prospective
study is needed.
Copyright © 2009 Shaista Safder et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Functional gastrointestinal disorders (FGID) aﬀect a large
percent of children and eﬀects quality of life. The exact
prevalence of FGID in children is unknown. One study
found 10–20% of children suﬀer from chronic abdominal
pain [1]. Also, 6% of middle school students and 15% of
high school students fulﬁll the criteria for irritable bowel
syndrome [2]. These children have a decreased quality of life
with increased school absenteeism, decreased play time, and
other signiﬁcant impairments.
According to the proposed biopsychosocial conceptu-
alization of functional gastrointestinal disorders, the auto-
nomic nervous system links the psychosocial factors with
the pathophysiological elements [3]. A role for abnormal
autonomic nervous system function is increasingly recog-
nized which may not be limited to the gastrointestinal tract.
In pediatrics, exploratory studies have found autonomic
dysregulation in pediatric FGID [4–6] .F G I D ’ sh a v eb e e n
associated with orthostatic intolerance (OI), mainly postural
tachycardia syndrome (POTS) and syncope [4, 6], but other
associations have not been carefully evaluated. Three main
types of orthostatic disorders have been described in patients
undergoingtilttabletesting(TTT):posturaltachycardiasyn-
drome (POTS), reﬂex syncope, and orthostatic hypotension
(OH).
POTS is deﬁned as an increase in heart rate (HR) from
supine to standing position of greater than 30bpm, without
sustained drop in blood pressure. This deﬁnition has a
stronger clinical implication if the increase in heart rate is2 Gastroenterology Research and Practice
associated with symptoms replicating the chief complaint for
the testing, like dizziness, headache, nausea, and so forth.
The symptoms of POTS and many of the symptoms of
functional gastrointestinal disorders, particularly dyspepsia,
overlap. When Sandroni et al. [7] described the symptoms
associated with POTS including dizziness, lightheadedness,
and lower extremity weakness, they also reported frequent
associated symptoms of dyspepsia, such as nausea, bloating,
early satiety, and abdominal pain. In addition, patients with
POTS who have an associated autonomic neuropathy harbor
more gastrointestinal symptoms than those who do not [5].
This association also holds true when explored from
the reverse, gastrointestinal perspective. Children with chief
complaintsofabdominalpainanddiagnosedwithfunctional
gastrointestinal disorders have dizziness (58%), headaches
(52%), while 10% have prominent fatigue, and 5% have
episodes of loss of consciousness [8–10]. Sullivan et al. [6],
also described similar ﬁndings in children with functional
gastrointestinal disorders, with lightheadedness and fatigue
in 46%, however this study was limited by a small sample
size and a skewed population that was sampled .
We have frequently observed the reproduction of gas-
trointestinal symptoms when the subject is upright during
the head-up tilt table test. The clinical implications and
associatedoutcomeofsuchﬁndingshavenotbeenevaluated.
Thepurposeofthisstudywastodetermine,throughareview
of comprehensive autonomic testing performed in children
with functional gastrointestinal disorders if replication of
symptoms during tilt test is associated with a diﬀerent
treatment outcome than when symptoms are not present
during TTT.
2.MaterialandMethods
2.1. Study Design. A retrospective University Hospitals Case
Medical Center Institutional Review Board approved chart
reviewwasconductedfromthePediatricAutonomicLabora-
tory database containing 419 pediatric records between 1994
and 2007. From this group, we selected only those children
referred for gastrointestinal (GI) complaints (n = 76). We
excluded children with a known organic gastrointestinal dis-
ease or genetic/metabolic abnormality. Most of the children
had been referred to the Autonomic Clinic by their pediatric
gastroenterologist or general pediatricians for evaluation of
dysautonomia as a possible cause of their gastrointestinal
complaints.
2.2. Testing. All patients underwent 4 tests of autonomic
function including 3 tests of cardiovascular function (the
cardiovascular responses to deep breathing, to the Valsalva
maneuver, and to tilt table testing) and one test of sweating,
the sudomotor axon reﬂex response. The patients stopped
any medications that could aﬀect autonomic function for
5h a l f - l i v e sp r i o rt ot e s t i n g ,s u c ha sb e t a - b l o c k e r s ,c a ﬀeine,
anticholinergic medications, and so forth.
TTT consisted of 20-minute supine rest on a motorized
tilt table prior to an upright tilt to 70
◦.C o n t i n u o u sB Pa n d
HR were monitored noninvasively in the supine position for
3minutes, andupright for10to40minutes. Thediastolic BP
normally decreases less than 10mmHg, and the systolic BP,
lessthan20mmHg,andHRshouldincreaselessthan30bpm
[9].
Deep breathing consists of 6 deep breaths per minute,
with the HR variation calculated from the best 6 of 12 cycles
(normal values in this age group > 22bpm [11]). Results are
reported as the average diﬀerence between inspiration and
expiration of the 5 best breaths. For the Valsalva maneuver,
the subject maintains a 40mmHg pressure gradient with an
open glottis for 15 seconds, while HR and blood pressure
(BP) are continuously monitored. The Valsalva ratio consists
of the fastest HR during pressure exertion (termed phase
II, sympathetically mediated) divided by the lowest HR
after pressure release (termed phase IV, parasympathetically
mediated). Normal values depend on age [11].
Sudomotor axon reﬂex response to the iontophoresis
of acetylcholine (10% with a 2mA current for 5 minutes,
recording sweat output for 10 minutes, “QSART”) across
the skin of the feet, calves, hands and upper arms, was
measured by standard methods [12]. Normal values vary by
body site and gender, and were not considered abnormal
unless abnormal axon reﬂex response found in 2 sites were
outside of the range of normal, deﬁning the presence of an
autonomic neuropathy.
2.3. Data Analysis. Patients were divided into two groups
on the basis of their symptoms during the TTT: patients
with reproducible GI complaints (RGI) and those without
(NRGI). The response to treatment was scored from 1 to
5 with 1 “much worse,” 2 “little worse” 3 “neither better
nor worse,” 4 “somewhat better” and 5 “much better.” The
scoreof5wasreservedforpatientswhosesymptomsresolved
completely.Foranalysispurposes,subjectswitha“somewhat
better” response (rating of 4) and those with a “much better”
(response rating of 5) were collapsed into a single group and
compared to all others. Thus a favorable treatment response
was ≥ 4 out of 5 on the symptom response scale.
Three orthostatic disorders were deﬁned for this group
of patients: POTS required an increase in (HR) of greater or
equal to 30bpm in the ﬁrst 10 minutes of upright position
duringtilttestassociatedwithsymptoms,andwithoutadrop
in blood pressure. While the adult deﬁnition also accepts
an absolute heart rate of 120bpm we did not include this
criterion in this population, since 120bpm may be represent
a normal (HR) in younger children. Reﬂex syncope required
an abrupt drop in blood pressure and often (HR) (over 3
minutes or less) leading to syncope or pre-syncope. OH was
deﬁnedbyasustaineddropinbloodpressureor ≥ 20mmHg
systolic or ≥ 10mmHg diastolic in the ﬁrst 3 minutes of
the tilt study. Patients with an orthostatic disorder who also
had syncope were classiﬁed in the group with the orthostatic
disorder, as this was considered to be the underlying process.
For example, if a patient had POTS and syncope, they were
placed in the POTS group.
The study population was described overall and by
group. Nominal variables were described by frequencies and
percents. Continuous variables were described using theGastroenterology Research and Practice 3
Table 1: Summary of demographic characteristics and results of autonomic testing in each group.
Overall N = 76 RGI n = 32 NRGI n = 44 P value
Mean age (years) ± SD 13.4 years ± 3.6 yrs 12.6 ±3.31 4 .1 ±3.70 .08
Male gender 25/76 (32%) 9 /32 (28%) 16/44 (36%) .46
Median duration of symptoms (range in months) 41.5 ±24.02 9 .3 ±30.95 1 ± 45.6 .04
24(1-156) 18(2-120) 35(1-156)
Abnormal Valsalva Ratio (no. subjects) 8/76 (10%) 1/32 (3%) 7/44 (15%) .13
Abnormal Deep Breathing (no. subjects) 7/76 (9%) 2/32 (6%) 5/44 (11%) .69
Either DB and Valsalva ratio abnormal 15/76 (20%) 3/32 (9%) 12/44 (27%) .13
Abnormal Axon-Reﬂex Response 23/76 (30%) 10/32 (31%) 13/44 (29%) .81
POTS on TTT 59/76 (77%) 28/32 (87%) 31/44 (70%) .09
Patients on Fludrocortisone 23/76 (30%) 15/32 (46%) 8/44 (18%) .01
No. Patients with ≥4/5 Treatment response to Fludrocortisone 13/76 (17%) 11/32 (34%) 2/44 (4%) .09
appropriate measures of central tendency and dispersion.
Groups were compared using two-sample tests of signiﬁ-
cance. Nominal variables were compared using Fisher’s exact
test, and continuous variables were compared using either a
two-sided t test, or Wilcoxon rank sum test, depending on
the distribution. All analyses were done using SAS, v 9.1 (the
SAS Institute, Carey, NC). The level of signiﬁcance was set at
0.05.
3. Results
Ofthe76childrenincludedinthestudy,51werefemaleswith
am e a na g eo f1 3 .4 ± 3.6y e a r s .I n3 2o u to f7 6c h i l d r e nt h e
tilt table test replicated their GI complaints (RGI) while in 44
it did not (NRGI). Table 1 characterizes the two groups and
Figure 1 describes the results of autonomic testing. The RGI
group was younger and had a shorter duration of symptoms.
Abdominalpainwasthemostfrequentchiefcomplaintinthe
R G Ig r o u p ,t h o u g hs o m es u b j e c t sh a dm o r et h a no n ec h i e f
complaint. The predominant complaints in each group are
summarized in Table 2,w i t hn od i ﬀerence between groups
(P = .17).
The symptom replicated during tilt was abdominal pain
in 28/32 (87%) of the RGI group, nausea 2/32 (6%) and
vomiting in 2/32 (6%). By deﬁnition, symptoms were not
replicated in the NRGI group (Figure 3). The RGI group had
a greater frequency of POTS than the NRGI group (88%)
28/32 versus (70%) 31/44 (p = 0.09, Table 1). Many patients
with POTS also had reﬂex syncope, present in 18/32 (56%)
in the RGI group and 10/44 (23%) in the NRGI group.
OH occurred in 1 subject in each group. Abnormal cardiac
reﬂexes (abnormal Valsalva maneuver or abnormal deep
breathing) were more common in the NRGI group, though
this did not reach statistical signiﬁcance. In the NRGI group,
8/44 children had normal tilt testing test (18%), whereas
only 1 patient had normal testing in the RGI group. All
but one patient on TTT in the RGI group showed some
form of orthostatic intolerance with patients having POTS,
syncope, OH or both POTS and syncope. The distribution
of abnormalities is rendered algorhythmically in Figure 1.
There was no signiﬁcant diﬀerence between quantitative
Table 2: Summary of the most common symptoms in each group.
Symptom Overall n = 76 RGI n = 32 NRGI n = 44
Abdominal pain 43/76 (56%) 23/32 (71%) 20/44 (45%)
nausea 8/76 (10%) 5/32 (15%) 3/44 (6%)
dizziness 13/76 (17%) 3/32 (9%) 10/44 (22%)
vomiting 13/76 (17%) 4/32 (12%) 9/44 (20%)
syncope 6/76 (7%) 2/32 (6%) 4/44 (9%)
fatigue 2/76 (2%) 1/32 (3%) 1/44 (2%)
diarrhea 5/76 (6%) 1/32 (3%) 4/44 (9%)
headache 5/76 (6%) 1/32 (3%) 4/44 (9%)
sudomotor axon reﬂex ﬁndings in the two groups (an
indicator of autonomic neuropathy).
Treatment was not standardized and generally selected
based on symptoms and results of the autonomic nervous
system testing, often with more than one agent (Table 3).
In addition, all patients were asked to supplement salt and
ﬂuids to their diet, and increase their physical activity. Not
surprisingly, patients in the RGI group were more often
treated with ﬂudrocortisone 15/32 (46%) aimed at their
orthostaticsymptoms(mainlyPOTS)comparedtotheNRGI
group where only 8/44 (18%) received ﬂudrocortisone P =
.01.Ofpatientsreceivingﬂudrocortisone,patientsintheRGI
group tended to beneﬁt more, with 11/15 (73%) reporting
an improvement in their symptoms versus 2/8 (25%) in the
NRGI group (Figure 2).
4. Discussion
This study divided patients with functional abdominal pain
into a subgroup whose symptoms were replicated during the
upright portion of the tilt table study (RGI) and a subgroup
wherethisdidnotoccur(NRGI).Theresultssuggestthatthis
classiﬁcationmaymakesensefrombothaphysiologicandan
outcome perspective. The RGI group tended to be younger,
with a shorter duration of symptoms, a preponderance of
abdominal pain, and a higher incidence of POTS. These
children appeared to respond better when treated for their
orthostatic symptoms with ﬂudrocortisone. In contrast, the4 Gastroenterology Research and Practice
All patients with GI complaints (n = 76; 25 male) who had autonomic testing
32 RGI (9 male) 44 NRGI (16 male) 
Normal 1  Normal 8  OI 31  OI 32  Non OI 4 
POTS 
28
Syncope
2
OH
1
POTS
31
OH
1
Abnormal 
DB 1 
Abnormal 
DB 1 
Abnormal 
Valsalva 1 
Abnormal 
DB 3 
Abnormal 
Valsalva 5 
Abnormal 
DB 2  
Abnormal 
Valsalva 2 
Figure 1: Result of Autonomic testing. OI: orthostatic intolerance, DB: Deep breathing, and OH: orthostatic hypotension.
RGI (N = 32) 
Florinef used in15 pts 
NRGI (N = 44) 
Florinef used in 8 pts 
Worse
2
Unknown 
effect 2  
Improved
2
No change 
2
Worse
1
Unknown 
effect 3 
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11
Figure 2: Fludrocortisone treatment eﬀect.
Table 3: Treatment choices in both groups.
Treatment
group
Overall RGI n = 32 NRGI n = 44
Volume
expansion/
Fludrocortisone
23/76 (30%) 15/32 (47%) 8/44 (18%)
Tricyclic
antidepressant
9/76 (12%) 6/32 (19%) 3/44 (7%)
Beta-blockers 25/76 (32%) 10/32 (31%) 15/44 (34%)
Cyproheptadine 3/76 (4%) 2/32 (6%) 1/44 (2%)
SSRI’s 18/76 (23%) 10/32 (31%) 8/44 (18%)
Antiepileptic 5/76 (6%) 2/32 (6%) 3/44 (7%)
Proamatine 9/76 (12%) 5/32 (16%) 4/44 (9%)
Neurontin 2/76 (2%) 1/32 (3%) 1/44 (2%)
Mestinon 1/76 (1%) 1/32 (3%) 0/44 (0%)
No Treatment 17/76 (22%) 3/32 (9%) 14/44 (31%)
older NRGI subgroup had less POTS, and most of the
abnormal autonomic reﬂexes in the entire cohort were
found in this subgroup. From an autonomic perspective, the
RGI group was quite homogeneous, as nearly all patients
had some form of orthostatic intolerance on TTT (POTS,
Syncope, and OH). On the other hand, the NRGI group
a p p e a r sm o r eh e t e r o g e n e o u s ,w i t hs o m es u b j e c t se n t i r e l y
normal, some with the same ﬁndings as the RGI group, and
some even more abnormal with abnormal cardiovascular
reﬂexes such as a reduced response to deep breathing or
reduced Valsalva ratio. Such a discrepancy between the two
groups further suggests that symptom replication by tilt
study may be physiologically important.
Onecouldimagineseveralexplanationsforthediﬀerence
between these groups. Both sets of children could be
suﬀeringfromthesamedisorder,buttheRGIgroupinwhom
abdominal pain predominated may have harbored more
bothersome symptoms, resulting in an earlier presentation.
According to this hypothesis, the disorder might evolve
through a phase in which symptoms are more variable
depending on patient activity, diet, position, and so forth,
(representedbytheRGIgroupinthisstudy)toaﬁnalstagein
which symptoms become “hard-wired,” here represented by
the NRGI group. Support for this notion can be drawn from
the chronic pain literature, where such a progression is well
recognized,forexample,incomplexregionalpainsyndrome,
and in chronic failed back syndrome [13, 14].
Alternatively, our ﬁndings could reﬂect 3 physiologically
distinct groups of children with functional abdominal pain.
The ﬁrst group (the entire RGI cohort) has symptom
replication on tilt table testing, owing to some type of
dynamic alteration in gastrointestinal blood ﬂow during
orthostaticchallenge,anabnormalitythatismoreresponsive
to medical management, with consequent better outcome.
This group might correspond to the term “gastrointestinal
vasomotor dysautonomia.” A second group, perhaps termed
“gastrointestinal neuropathic dysautonomia” would consti-
tute the NRGI subgroup with abnormal autonomic testing,Gastroenterology Research and Practice 5
76 patients referred with GI complaints who 
underwent autonomic testing
32 with reproducible GI 
complaints during 
44 with nonreproducible GI  
complaints during testing
28
abdominal pain
2
nausea
2
vomiting
Figure 3: Gastrointestinal (GI) Symptom proﬁle of patients who underwent autonomic testing.
reﬂecting a static abnormality of autonomic innervation to
the gut, perhaps resulting in abnormal motility, and less
responsiveness to treatment. The third group, “gastrointesti-
nal nonautonomic dysfunction” would comprise the NRGI
subgroup with entirely normal autonomic testing, in whom
there is neither a dynamic blood ﬂow abnormality, nor a
static loss of innervation with dysmotility, and where the
abdominalpainappearstobearnorelationtoanyautonomic
abnormality.
The concept of a gastrointestinal vasomotor disturbance
accounting for symptomology in the RGI group dovetails
well with some recent POTS investigations, emphasizing
mesenteric hyperemia as a major ﬁnding in certain POTS
subgroups [15]. As postulated by Stewart et al. the mecha-
nism of this hyperemia could include a focal denervation, or
more likely, local neuroendocrine factors in the enteric ner-
vous system, such as nitric oxide or vasoactive intestinal pep-
tideresultingininappropriatevasodilation.Otherconsidera-
tions might include abnormal autonomic-enteric inﬂuences,
or even central nervous system alterations, as postulated
in abdominal migraine. Serotonergic pathways could play a
role here, since both POTS [16] and functional abdominal
disorders (e.g., IBS [17]) have demonstrated serotonergic
abnormalities. Future studies could determine whether there
is an association between splanchnic hyperemia and the
presence of tilt-induced gastrointestinal symptoms and the
potential role of gastrointestinal motility.
Clinically, the classiﬁcation into 3 groups may have
someutility.The“gastrointestinalvasomotordysautonomia”
subgroup is slightly younger, have had symptoms for less
time, and respond better to treatment. The “gastrointesti-
nal neuropathic dysautonomia” and “gastrointestinal non-
autonomicdysfunction”groups,bothcontainedintheNRGI
group in this study, may well diﬀer in characteristics, but will
require a larger prospectively gathered cohort for a better
comparison of their features and outcomes. Utilizing this
putative classiﬁcation to classify patients prospectively will
also likely determine which treatment modalities provide
optimal beneﬁt in each group, and further delineate the
phenotype of these children.
A majority of patients, regardless of subgroup, demon-
strated POTS as the primary abnormality on autonomic test-
ing. The pathophysiology underlying this disorder remains
elusive to-date, although, akin to the proposed classiﬁcation
above for functional gastrointestinal disorders, one can
group patients into those who have abnormal autonomic
reﬂexes and those who do not [5]. POTS represents a
form of nonspeciﬁc autonomic dysregulation, which may be
classiﬁed as resulting from either a peripheral or a central
autonomic nervous system etiology, based on the axon reﬂex
response [5]. Interestingly, those with a presumed peripheral
cause in this particular study had a greater frequency of
migraineheadacheandgastrointestinalsymptoms.However,
in the present study we did not ﬁnd a diﬀerence in axon
reﬂex responses, and thus no suggestion that a peripheral
autonomic process is more likely in one dysautonomic group
than in the other. This could, however, relate to the lack of
power in the present study to detect such a diﬀerence.
This study has several additional limitations. The large
number of children with functional abdominal pain who
had POTS (77%, Table 1) could result from a referral bias,
since many patients were sent for evaluation of dysau-
tonomia. A randomly selected population of patients with
functional gastrointestinal disorders may harbor less POTS.
Secondly, since children are being treated clinically without
a standardized care-path, treatment beneﬁt is diﬃcult to
assess objectively, and we do not truly know the number of
patients who improved with medications targeted at various
putative mechanisms. For the same reasons, we do not
know how many patients beneﬁted from physical activity
and other forms of conditioning, which we commonly
prescribe. Thirdly, we do not have adequate information
about puberty and menstrual status in our patients, to know
the signiﬁcance of this factor in the subgroups. Finally, the
study is retrospective, and subject to well-known biases of
such a design, as already alluded to earlier in the discussion.
Nonetheless,itisfairtosummarizebystatingthatautonomic
testing reveals diﬀerent and interesting subpopulations of
patients with functional abdominal disorders, which may
harbor physiologic importance, and ultimately lead to a
better understanding of the mechanism of these symptoms
and their treatment.
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